Dr. Errol Gordon, MD
Claim this profileSt. John Medical Center
Studies Stroke
Studies Ischemic Injury
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Errol Gordon, MD is currently running
Tissue Kallikrein
for Ischemic Stroke
This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limited treatment options. Participants who have or will receive mechanical thrombectomy (MT) are not eligible for participation. Additionally, participants who have received fibrinolytics are excluded unless they experience a persistent neurological deficit of moderate severity six or more hours after fibrinolytic treatment. Participants considered for this trial should not be denied the use of standard of care (SoC) AIS therapies, such as fibrinolytics or MT, when appropriate. The double-blinded study will be randomized and placebo-controlled at up to approximately 100 sites.
Recruiting0 awards Phase 2 & 37 criteria
Recombinant Factor VIIa
for Hemorrhagic Stroke
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy. FASTEST Part 2 is an extension of the FASTEST Trial where the subgroups include only those treated within 2 hours with a positive spot sign on a baseline CT angiogram.
Recruiting1 award Phase 32 criteria
More about Errol Gordon, MD
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Errol Gordon, MD has experience with
- Placebo
- Recombinant Human Tissue Kallikrein
- Recombinant Activated Factor VII (rFVIIa)
- Recombinant Factor VIIa
- Argatroban
- Eptifibatide
Breakdown of trials Errol Gordon, MD has run
Stroke
Ischemic Injury
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Errol Gordon, MD specialize in?
Errol Gordon, MD focuses on Stroke and Ischemic Injury. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Errol Gordon, MD currently recruiting for clinical trials?
Yes, Errol Gordon, MD is currently recruiting for 3 clinical trials in Tulsa Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Errol Gordon, MD has studied deeply?
Yes, Errol Gordon, MD has studied treatments such as Placebo, Recombinant human tissue kallikrein, Recombinant Activated Factor VII (rFVIIa).
What is the best way to schedule an appointment with Errol Gordon, MD?
Apply for one of the trials that Errol Gordon, MD is conducting.
What is the office address of Errol Gordon, MD?
The office of Errol Gordon, MD is located at: St. John Medical Center, Tulsa, Oklahoma 74104 United States. This is the address for their practice at the St. John Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.